日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tympanometric profiles for Chinese older adults

中国老年人的鼓室图谱

Manchaiah, Vinaya; Durisala, Naresh; Marimuthu, Vijay

Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and Lomustine

接受 Galunisertib、洛莫司汀或 Galunisertib 与洛莫司汀联合治疗的复发性胶质母细胞瘤患者的生物标志物和组织病理学评估

David Capper, Andreas von Deimling, Alba A Brandes, Antoine F Carpentier, Santosh Kesari, Juan M Sepulveda-Sanchez, Helen R Wheeler, Olivier Chinot, Lawrence Cher, Joachim P Steinbach, Pol Specenier, Jordi Rodon, Ann Cleverly, Claire Smith, Ivelina Gueorguieva, Colin Miles, Susan C Guba, Durisala De

Preclinical assessment of galunisertib (LY2157299 monohydrate), a first-in-class transforming growth factor-β receptor type I inhibitor

首创转化生长因子-β 受体 I 型抑制剂 galunisertib(LY2157299 一水合物)的临床前评估

Jonathan M Yingling, William T McMillen, Lei Yan, Huocong Huang, J Scott Sawyer, Jeremy Graff, David K Clawson, Karen S Britt, Bryan D Anderson, Douglas W Beight, Durisala Desaiah, Michael M Lahn, Karim A Benhadji, Maria J Lallena, Rikke B Holmgaard, Xiaohong Xu, Faming Zhang, Jason R Manro, Philip

A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma

一项 II 期随机研究,比较了加鲁尼塞替单药治疗或加鲁尼塞替联合洛莫司汀治疗与洛莫司汀单药治疗在复发性胶质母细胞瘤患者中的疗效。

Brandes, Alba A; Carpentier, Antoine F; Kesari, Santosh; Sepulveda-Sanchez, Juan M; Wheeler, Helen R; Chinot, Olivier; Cher, Lawrence; Steinbach, Joachim P; Capper, David; Specenier, Pol; Rodon, Jordi; Cleverly, Ann; Smith, Claire; Gueorguieva, Ivelina; Miles, Colin; Guba, Susan C; Desaiah, Durisala; Lahn, Michael M; Wick, Wolfgang

Relative bioavailability of three formulations of galunisertib administered as monotherapy in patients with advanced or metastatic cancer

三种不同制剂的加鲁尼塞替单药治疗晚期或转移性癌症患者的相对生物利用度

Gueorguieva, Ivelina; Cleverly, Ann; Desaiah, Durisala; Azaro, Analia; Seoane, Joan; Braña, Irene; Sicart, Elisabet; Miles, Colin; Lahn, Michael M; Mitchell, Malcolm I; Rodon, Jordi

PRONOUNCE: randomized, open-label, phase III study of first-line pemetrexed + carboplatin followed by maintenance pemetrexed versus paclitaxel + carboplatin + bevacizumab followed by maintenance bevacizumab in patients ith advanced nonsquamous non-small-cell lung cancer

PRONOUNCE:一项随机、开放标签的III期研究,比较一线培美曲塞+卡铂治疗后序贯培美曲塞维持治疗与紫杉醇+卡铂+贝伐单抗治疗后序贯贝伐单抗维持治疗在晚期非鳞状非小细胞肺癌患者中的疗效。

Zinner, Ralph G; Obasaju, Coleman K; Spigel, David R; Weaver, Robert W; Beck, J Thaddeus; Waterhouse, David M; Modiano, Manuel R; Hrinczenko, Borys; Nikolinakos, Petros G; Liu, Jingyi; Koustenis, Andrew G; Winfree, Katherine B; Melemed, Symantha A; Guba, Susan C; Ortuzar, Waldo I; Desaiah, Durisala; Treat, Joseph A; Govindan, Ramaswamy; Ross, Helen J

Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway.

galunisertib(LY2157299 一水合物)是一种转化生长因子-β信号通路的小分子抑制剂,目前正在进行临床开发

Herbertz Stephan, Sawyer J Scott, Stauber Anja J, Gueorguieva Ivelina, Driscoll Kyla E, Estrem Shawn T, Cleverly Ann L, Desaiah Durisala, Guba Susan C, Benhadji Karim A, Slapak Christopher A, Lahn Michael M

Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer

在针对晚期癌症患者的 I 期研究中,对转化生长因子-β 受体 I 激酶抑制剂 galunisertib 进行药代动力学、药效学和生物标志物评估

Rodón, Jordi; Carducci, Michael; Sepulveda-Sánchez, Juan M; Azaro, Analía; Calvo, Emiliano; Seoane, Joan; Braña, Irene; Sicart, Elisabet; Gueorguieva, Ivelina; Cleverly, Ann; Pillay, N Sokalingum; Desaiah, Durisala; Estrem, Shawn T; Paz-Ares, Luis; Holdhoff, Matthias; Blakeley, Jaishri; Lahn, Michael M; Baselga, Jose

A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder

对阿托莫西汀滥用潜力评估的综述:一种用于治疗注意力缺陷/多动障碍的非兴奋剂药物

Upadhyaya, Himanshu P; Desaiah, Durisala; Schuh, Kory J; Bymaster, Frank P; Kallman, Mary J; Clarke, David O; Durell, Todd M; Trzepacz, Paula T; Calligaro, David O; Nisenbaum, Eric S; Emmerson, Paul J; Schuh, Leslie M; Bickel, Warren K; Allen, Albert J

Efficacy and safety of duloxetine 60 mg once daily in major depressive disorder: a review with expert commentary

度洛西汀60毫克每日一次治疗重度抑郁症的疗效和安全性:专家评论综述

Ball, Susan G; Desaiah, Durisala; Zhang, Qi; Thase, Michael E; Perahia, David G S